Na, K, ATPase is the enzyme responsible for the active transport of sodium out of the cell and potassium into the cell, and is simply referred to as a sodium pump (Skou 1965 ; Glynn and Karlish 1975) . Thyroid hormones are known to enhance the Na, K, ATPase activity in rodent tissues including heart (Philipson and Edelman 1977a and b) , liver (Ismail-Beigi and Edelman 1970 ; Ismail-Beigi and Edelman 1971 ; York et al. 1978 , Gambert et al. 1981 , skeletal muscle (Asano et al. 1976 ) and kidney (Ismail-Beigi and Edelman 1970 ; Ismail-Beigi and Edelman 1971; Gambert et al. 1981: Lo and , probably by increasing the synthesis of this enzyme (Lo and Edelman 1976) . Edelman and Ismail-Beigi (1974) proposed that the calorigenic effect of thyroid hormone could be ascribed to the enhanced activity of Na, K, ATPase, which in turn fascilitated mitochondrial respiration and calorigenesis by lowering intracellular ATP-ADP ratio.
Very little is known about the thyroidal regulation of this enzyme activity in human tissues. Reduced activity of ouabain-sensitive ATPase in erythrocyte ghost from patients with hyperthyroidsm was reported by Cole and Waddell (1976) . Recently Arnott et al. (1982) showed that lymphocyte ouabain binding capacity assessed by [3H]-ouabain binding was reduced in hypothyroid patients compared with normal subjects. However, these workers could not observe any change in this enzyme in lymphocytes from patients with hyperthyroidism.
Thus, the effect of thyroid hormones on Na, K, ATPase activity in human tissues remains to be elucidated.
In this paper we present data on the maximum ouabain binding capacity of erythrocytes from hyperthyroid patients. Other workers (Schmalzing et al. 1980; Gelbert and Goldman 1977) Their thyroid status were evaluated by the clinical signs and symptoms and also by the results of T3 and T4 radioimmunoassays.
These patients were normotensive, and showed no abnormalities in serum electrolytes, creatinine, blood urea nitrogen or in the complete blood count.
The control subjects were laboratory personnel ranging in age from 29 to 57 years. They were normotensive, and none of them was obese.
Venous blood was drawn into an heparinized syringe after an overnight fast for all subjects. Erythrocytes were prepared according to the procedure described by Gambhir et al. (1977) 
Results
Individual values for maximum ouabain binding capacity of cells from normal subjects and patients with hyperthyroidism are shown in Fig. 1 Figure 2 shows the relationship between circulating thyroid hormone levels and maximum ouabain binding capacity in erythrocytes from patients and controls. As can be seen, a close inverse correlation was found between these variables (r = -0.766 ; p <0.001 for T3 or r=-0.870 ; p<0.001 for T4). The correlation coefficients for the relationship between hormones and serum total cholesterol which was determined in 20 out of 22 subjects were -0.342 for T3 (ns) and 
Discussion
The present study first demonstrated that the maximum ouabain binding capacity assessed by ouabain binding assay had a close inverse correlation with serum T3 (r= 0.001) levels, and suggests that the Na, K, ATPase activity in human erythrocytes is regulated by circulating thyroid hormones. Despite the indirect nature of ATPase assay, the number of ouabain binding sites assessed by specific binding of ouabain has been repeatedly shown to correlate with the activity of this enzyme (Schmalzing et al. 1981 ; Gelbert et al. 1977) . In accordance with the present data, the Vmax value of ouabain (Na, K, ATPase-mediated) rubidium uptake by erythrocytes from hyperthyroid patients was found to be lower than the value in normals in our preliminary experiment (unpublished observation).
An increase in the activity of the erythrocyte sodium pump has been described in deseases such as a certain type of morbid obesity , hereditary hemolytic syndromes (Wiley 1971; Wiley et al. 1975) , protein-calorie malnutrition (Kaplay 1978) and glucocorticoid excess (Kaji et al. 1981) . Patients with obesity (De Luise et al. 1980 ; Klimes et al. 1982) , myotonic muscular dystrophy (Lomber et al. 1981 ) and uremia (Smith and Welt 1976) were shown to have fewer pump units than controls. In hyperthyroid patients, reduced activity of the erythrocyte sodium pump has been suggested by several investigators because of an elevated concentration of sodium within their erythrocytes (Boeckelman 1958 ; Goolden et al. 1971 ). Cole and Waddell (1976) confirmed these findings by measuring ouabain-sensitive ATPase activity in erythrocyte membranes from hyperthyroid patients. Although these workers noted a close inverse correlation between this enzyme activity and serum T4 level in a course of treatment with antithyroid drug or radioactive iodine in one patient, they could not observe a significant correlation between these variables in other patients they had examined.
In contrast with the present data, thyroid hormones are known to enhance Na, K, ATPase activity in rodent tissues including heart Edelman 1977a and b), liver (Ismail-Beigi and Edelman 1970; IsmailBeigi and Edelman 1971 ; York et al. 1978 ; Gambert et al. 1981) , skeletal muscle (Asano et al. 1976 ) and kidney (Ismail-Beigi and Edelman 1970 ; Ismail-Beigi and Edelman 1971 ; Gambert et al. 1981 ; Lo and Edelman 1976a and b) . It is not clear whether these difference are due to a species or tissue specificity of thyroid hormone effect. The latter explanation is favored by the finding that erythrocyte from T3 treated rats showed a significant elevation of intracellular sodium concentration (Ismail-Beigi and Edelman 1973) . The data imply that the activity of Na, K, ATPase may be reduced in erythrocytes from hyperthyroid rats, despite the fact that the increase in the activity of this enzyme was shown in homogenates of liver and kidney in a parallel experiment.
The mechanism by which thyroid hormone reduces the number of sodium pump units in erythrocytes is unknown. It is generally accepted that the thyroid hormone action is initiated by its binding to nuclear receptor of the thyroid hormone (Oppenheimer et al. 1972 ; Samuels et al. 1973) . Therefore, it can be speculated that the hormone reduces the number of erythrocyte sodium pump units in a stage of erythropoiesis, rather than in a stage of nonnucleated matured cell. It has recently been shown, however, that specific binding sites also exist on the plasma membranes of rat liver (Pliam and Goldfine 1977) . Thus, the direct action of thyroid hormone on the plasma membranes of matured erythrocytes cannot be excluded.
Whatever the mechanism of this change is, the maximum ouabain binding capacity in erythrocytes may provide a reliable cellular index of thyroid hormone action in hyperthyroid patients, if other causes of a change in sodium pump activity are excluded. The relationship between circulating thyroid hormones and ouabain binding capacity was much closer than that observed between hormones and serum total cholesterol levels which were in use as a convenient cellular index of thyroid status. Further studies on the erythrocyte sodium pump activity in hypothyroidism and also the effect of treatment of hypo-and hyperthyroidism on this enzyme activity are being carried out in this laboratory.
Note Added in Proof.
Since this manuscript was submitted, De Luise et al. (1983) have presented data showing that the erythrocyte ouabain binding capacity was reduced in hyperthyroidism.
These authors, however, could not observe a significant correlation between the extent of the reduction in erythrocyte ouabain binding capacity and serum T3 or T4 levels. While these results are apparently different from ours, the cause of the discrepancy is obscure.
